Relafen 750, or Relafen, or Naproxcinod, or the medication represents a targeted approach to pain management , viewed from a biochemical pharmacy perspective. This formulation, comprising naproxcinod, attempts to impact cyclooxygenase (COX) activity, specifically COX-2, even demonstrating reduced